company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2922339.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4761.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,81134.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3008234.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,849510.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,38247.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,38247.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,,totalassets,Total Assets,=,debit,usd,3895991.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,202751.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,167813.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,54459.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,425023.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,425023.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,8111548.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-4640580.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3470968.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3470968.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3470968.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q2,,2011-06-30,2011-08-12 15:41:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3895991.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2270416.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,41342.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,32607.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2344365.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,927993.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,38247.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,38247.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,,totalassets,Total Assets,=,debit,usd,3310605.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,236929.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,168569.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,66496.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,471994.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,471994.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,8181479.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-5342868.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2838611.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2838611.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2838611.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2011.0,Q3,,2011-09-30,2011-11-08 13:45:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3310605.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2443477.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22611.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,72687.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2538775.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1163020.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,,totalassets,Total Assets,=,debit,usd,3724522.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,199515.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,39187.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,81289.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,319991.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,319991.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,10415648.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-7011117.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3404531.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3404531.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3404531.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q1,,2012-03-31,2012-05-15 14:48:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3724522.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,7625277.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13648.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,88589.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7727514.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1167169.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,,totalassets,Total Assets,=,debit,usd,8917410.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,276326.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,67117.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,72234.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,415677.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,415677.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,16455968.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-7954235.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,8501733.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,8501733.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,8501733.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q2,,2012-06-30,2012-08-14 16:15:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,8917410.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6445441.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,66816.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,86076.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6598333.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1270503.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,22727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,,totalassets,Total Assets,=,debit,usd,7891563.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,394528.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,61872.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,87845.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,544244.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,544244.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,16542783.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-9195464.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,7347319.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,7347319.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7347319.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2012.0,Q3,,2012-09-30,2012-11-08 06:06:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7891563.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,9638768.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,688691.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,134063.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,10461522.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1549684.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,90000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,97119.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,187119.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,,totalassets,Total Assets,=,debit,usd,12198325.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,267632.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,707148.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,111029.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,180000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1265809.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,608256.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,608256.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1874065.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,23796898.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-13472638.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,10324260.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,10324260.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,10324260.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q1,,2013-03-31,2013-05-15 14:54:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,12198325.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,5754579.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,75045.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,92748.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,5922372.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1449458.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,88750.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,328185.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,416935.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,,totalassets,Total Assets,=,debit,usd,7788765.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,291962.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,735727.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,162807.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,293449.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,1483945.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,535266.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,535266.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2019211.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,23978803.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-18209249.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5769554.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5769554.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5769554.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q2,,2013-06-30,2013-08-12 20:36:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,7788765.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6429712.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,407560.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,36564.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6873836.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1661551.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28994423.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,452805.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,29447228.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,,totalassets,Total Assets,=,debit,usd,37982615.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1407516.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,102387.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,808568.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2318471.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,4785320.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4785320.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7103791.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,52444519.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-21565695.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,30878824.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,30878824.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,30878824.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2013.0,Q3,,2013-09-30,2013-11-14 16:36:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,37982615.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29949000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,657000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,626000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,31232000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2359000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,24041000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,32735000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,57024000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,,totalassets,Total Assets,=,debit,usd,90615000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1686000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1174000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,674000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1717000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5251000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10317000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,81000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,14248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,1543000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,25000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,26214000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,31465000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,102104000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-42954000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59150000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59150000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59150000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q1,,2014-03-31,2014-05-14 16:10:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,90615000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50155000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,576000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,705000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,51436000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2349000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,24041000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,32149000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,345000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,56535000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,,totalassets,Total Assets,=,debit,usd,110320000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2608000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1267000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,476000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2559000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6910000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,9442000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,105000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,14248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,1591000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25386000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,32296000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,129432000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-51408000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78024000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78024000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78024000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q2,,2014-06-30,2014-08-06 17:11:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,110320000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44269000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,986000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,586000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,45841000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2360000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,24041000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,31563000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,324000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,55928000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,,totalassets,Total Assets,=,debit,usd,104129000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3655000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1489000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1428000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2132000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8704000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8446000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,102000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,14248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,1639000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24435000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33139000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,130003000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-59013000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,70990000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,70990000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,70990000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2014.0,Q3,,2014-09-30,2014-11-04 14:48:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,104129000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60501000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,784000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,879000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62164000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2540000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,11500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,24041000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30390000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,622000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,66553000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,,totalassets,Total Assets,=,debit,usd,131257000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4537000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1886000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1082000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1899000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9404000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1033000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12368000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,796000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,21853000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,31257000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,177956000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-77956000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,100000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,100000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,100000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q1,,2015-03-31,2015-05-05 17:10:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,131257000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,51699000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,898000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1210000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,53807000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2824000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,21500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,12470000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4135000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,602000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,37478000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,76185000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,,totalassets,Total Assets,=,debit,usd,132816000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4613000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2474000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,909000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2365000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10361000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6868000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,11135000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,1633000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,851000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,10714000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31201000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,41562000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,180168000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-88914000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,91254000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,91254000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,91254000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q2,,2015-06-30,2015-08-07 16:28:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,132816000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59067000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,64386000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,622000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,731000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,124806000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3813000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,171500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,20626000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4023000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,527000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,196676000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,,totalassets,Total Assets,=,debit,usd,325295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,18577000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1619000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3215000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,26067000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5646000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,111413000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,34507000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,877000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,152443000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,178510000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,181656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-89853000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54386000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,146189000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,146189000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,596000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,146785000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2015.0,Q3,,2015-09-30,2015-11-13 21:46:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,325295000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20813000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,46183000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1146000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1875000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1715000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71732000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7436000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,169628000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,20626000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3801000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,556000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,194611000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,,totalassets,Total Assets,=,debit,usd,273779000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,16949000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3139000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6382000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1957000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28427000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3113000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,118217000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,35047000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,12000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,156389000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,184816000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,189843000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-131719000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,36690000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,94814000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,94814000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-5851000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,88963000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q1,,2016-03-31,2016-05-09 21:43:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,273779000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,98179000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34946000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,10000000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,867000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,556000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1715000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,146263000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9203000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,171098000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,20626000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3690000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,524000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,195938000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,,totalassets,Total Assets,=,debit,usd,351404000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,17067000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4423000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37102000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2435000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,61027000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1801000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,118289000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,35047000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,12000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,155149000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,216176000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,336959000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-176668000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25454000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-43502000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,142243000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,142243000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-7015000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,135228000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q2,,2016-06-30,2016-08-08 11:28:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,351404000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,66480000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1241000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,600000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,526000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1062000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1927000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71836000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10083000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,171421000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,20626000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3579000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1513000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,197139000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,,totalassets,Total Assets,=,debit,usd,279058000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,17188000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1377000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4474000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9186000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3818000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36043000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,458000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,135016000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,35047000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,170521000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,206564000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,336620000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-162299000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-51491000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,328000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-43502000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,79656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,79656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-7162000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,72494000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2016.0,Q3,,2016-09-30,2016-11-09 15:37:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,279058000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33919000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1265000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2338000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3272000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1299000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,42093000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16958000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,188054000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,36903000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,57469000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3751000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,286177000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,,totalassets,Total Assets,=,debit,usd,345228000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,41401000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11607000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4158000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9666000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5001000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,71833000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,26083000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,136442000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,48764000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,211289000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,283122000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,304616000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-197316000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-56000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,57780000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,57780000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,4326000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,62106000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q1,,2017-03-31,2017-05-15 16:05:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,345228000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53681000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,656000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2376000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2414000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1468000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,60595000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18044000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,191952000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38298000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,72330000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3549000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,306129000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,,totalassets,Total Assets,=,debit,usd,384768000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,50560000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9641000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6148000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9680000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,3254000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,79283000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,26541000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,134598000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,48150000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,209289000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,288572000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,353171000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-211503000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,218000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92422000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92422000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,3774000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,96196000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q2,,2017-06-30,2017-08-09 16:41:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,384768000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38323000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,888000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1693000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2279000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1525000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,44708000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18969000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,271666000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38300000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,71675000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3440000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,385081000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,,totalassets,Total Assets,=,debit,usd,448764000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,47089000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12984000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4441000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14679000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4158000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,83351000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,24575000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,132890000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,105659000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,263124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,346475000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,357907000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-213565000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,123000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,95001000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,95001000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,7288000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,102289000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2017.0,Q3,,2017-09-30,2018-02-26 21:50:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,448764000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24252000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,444000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3912000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6190000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1771000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,36569000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19494000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,269085000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38298000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,70352000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3081000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,380816000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,,totalassets,Total Assets,=,debit,usd,436879000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,26427000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9014000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8832000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2747000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4504000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,51524000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5501000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,124341000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,14640000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,144482000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,196006000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,480701000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-196784000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,352000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,234805000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,234805000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,6068000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,240873000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q1,,2018-03-31,2018-05-10 17:21:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,436879000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46784000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,323000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2204000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5002000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,433000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,54746000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19893000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,266980000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38298000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,69690000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2914000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,377882000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,,totalassets,Total Assets,=,debit,usd,452521000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,16440000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9941000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4226000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2121000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6671000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,39399000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16203000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,124173000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,13281000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,153657000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,193056000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,574328000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-270646000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,153000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,254371000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,254371000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,5094000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,259465000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q2,,2018-06-30,2018-08-09 17:21:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,452521000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,135441000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,297000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2278000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6805000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,424000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,145245000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,21467000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,266073000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38298000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,69133000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,47740000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,421244000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,,totalassets,Total Assets,=,debit,usd,587964000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,43160000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17203000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12938000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,941000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8168000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82410000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,145535000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,123987000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12472000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,281994000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,364404000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,588951000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-317974000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,79000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,221592000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,221592000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,1968000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,223560000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2018.0,Q3,,2018-09-30,2018-11-09 17:07:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,587964000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90971000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,9600000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,391000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7409000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4568000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5455000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,193000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,118579000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,28900000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,264083000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38300000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,65817000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,93789000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,461989000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,,totalassets,Total Assets,=,debit,usd,609474000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,19990000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14652000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23590000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3157000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,10159000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2534000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,74082000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,229662000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,116258000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,9230000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,62129000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,417279000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,491361000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,657128000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-475821000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,100000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,131943000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,131943000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-13830000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,118113000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q1,,2019-03-31,2019-05-15 17:00:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,609474000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61385000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,9592000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,316000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9786000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,6631000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5493000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,303000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,93506000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30829000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,262517000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38300000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,64825000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,97068000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,462710000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,,totalassets,Total Assets,=,debit,usd,587043000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,43569000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,24886000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17383000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3350000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,12500000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10301000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,111989000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,223589000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,115983000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,8923000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,71943000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,420438000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,532427000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,665528000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-532583000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,48000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,83529000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,83529000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-28913000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,54616000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q2,,2019-06-30,2019-08-09 16:49:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,587043000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34649000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,9592000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,94000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,11560000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4335000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7122000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,216000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,67568000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,30338000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,262248000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,38298000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,64299000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,98124000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,462969000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,,totalassets,Total Assets,=,debit,usd,560875000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,37189000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26750000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18478000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3613000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,14665000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,12018000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,112713000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,234370000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,115611000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,8634000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,82878000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,441493000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,554206000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,692486000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-596998000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-49464000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-129000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,45895000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,45895000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-39226000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,6669000.0
Sorrento Therapeutics Inc,SRNE,549300RH23PRR3M13410,0000850261,2019.0,Q3,,2019-09-30,2019-11-08 20:46:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,560875000.0
